Premium
Acute Knockdown of MG29 in Mouse Muscle Cells Reveals Signaling Mechanisms Associated with Polyunsaturated Fatty Acid (PUFA) – Implications for Sarcopenia
Author(s) -
Huang Jian,
Wang Zhiying,
Brotto Leticia,
Weisleder Noah,
Brotto Marco
Publication year - 2021
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2021.35.s1.02363
Subject(s) - gene knockdown , skeletal muscle , microbiology and biotechnology , myogenesis , myocyte , biology , sarcopenia , transfection , chemistry , cell culture , endocrinology , genetics
Estimates of humans with sarcopenia (i.e., the age related loss of muscle loss and strength) ranges from 30% to over 70% depending on the age group, and specific population studied. Mitsugumin 29 (MG29), a muscle‐specific protein, is a member of the synaptophysin‐like protein family (SYPL2) that contain MAL and related proteins for vesicle trafficking and membrane link (MARVEL) domains. MG29 is important for the formation of the transverse‐tubule (TT) system in skeletal muscles, efficient signaling between RyR1 and the store‐operated Ca 2+ entry (SOCE) machinery, and maintenance of lipid content of the sarcolemmal membrane. Our previous in vivo studies using a global knockout model of MG29 suggested a role of MG29 in the aging decline in muscle function. To avoid potential adaptive effects of the global absence of MG29, we also tested the siRNA‐mediated acute knockdown of MG29 in mouse primary skeletal muscle cells, which led to extensive myogenic changes characterized by increased myogenic differentiation that led to abnormally thinner and longer myotubes. To examine the mechanistic basis of these changes, we measured changes in lipid signaling following knockdown of MG29. We collected both cell culture medium and cell homogenates 72 h after siRNA transfection, and applied a custom‐targeted LC/MS lipidomics approach to quantify specific Lipid Signaling Mediators (LMs) in cell culture media and we used our customized skeletal muscle‐specific RT‐qPCR gene array to investigate specific genes showing alteration expression following acute MG29 knockdown. Compared with negative control siRNA treated cells, in MG29 siRNA treated cells, the cell culture media levels of arachidonoylethanolamine (AEA), oleoylethanolamide (OEA) increased significantly ( p < 0.05) and the levels of prostaglandin D2 (PGD2), 9,10‐DiHOME, 9‐HOTrE, 9‐HODE decreased significantly ( p < 0.05). In addition, the PCR gene array revealed that in MG29 siRNA treated cells the expression of Cacna1s , RyR3 , Btk and Sod3 increased 2.6 ± 0.48, 4.5 ± 0.89, 2.7 ± 0.51 and 6.5 ± 1.06 fold, respectively, while Fkbp1b and Ccl2 decreased 2.8 ± 0.38 and 7.3 ± 1.74 fold, respectively. These genes have function in calcium signaling and homeostasis and oxidative stress as well as inflammation and immune‐regulation. We conclude that MG29 modulation of myogenic differentiation occurs via a complex signaling mechanism related to changes in LMs derived from polyunsaturated fatty acid (PUFA). This study further positions MG29 as an important regulator of signaling pathways associated with intracellular calcium homeostasis, oxidative stress, and inflammation, which emphasizes the role of MG29 as an orchestrator of alterations in skeletal muscle during sarcopenia.